Bredt, David S.
Johnson & Johnson Pharmaceutical Research & Development, Raritan,
United States
2025 Rank: 29768
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Neurology & Neurosurgery
SubField 2:
Biochemistry & Molecular Biology
Rank in SubField 1: 1371 out of 360881 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 29768 | 34279 |
| Total Cites | 1778 | 1815 |
| H-index | 14 | 14 |
| Hm-index | 7 | 7 |
| Number of Single Authored Papers | 9 | 9 |
| Total Cites to Single Authored Papers | 19 | 19 |
| Number of Single+First Authored Papers | 23 | 23 |
| Total Cites to Single+First Authored Papers | 107 | 107 |
| Number of Single+First+Last Authored Papers | 118 | 118 |
| Total Cites to Single+First+Last Authored Papers | 436 | 437 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1568 | 1597 |
| Ratio of Total Citations to Distinct Citing Papers | 1.13 | 1.14 |
| Self-Citation Percentage |
2.04%
|
|
Bredt, David S.
Johnson & Johnson Pharmaceutical Research & Development, Raritan,
United States
2022 Rank: 16176
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Neurology & Neurosurgery
SubField 2:
Biochemistry & Molecular Biology
Rank in SubField 1: 961 out of 305851 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 16176 | 17813 |
| Total Cites | 1283 | 1355 |
| H-index | 17 | 18 |
| Hm-index | 8 | 8 |
| Number of Single Authored Papers | 9 | 9 |
| Total Cites to Single Authored Papers | 25 | 25 |
| Number of Single+First Authored Papers | 23 | 23 |
| Total Cites to Single+First Authored Papers | 162 | 162 |
| Number of Single+First+Last Authored Papers | 118 | 118 |
| Total Cites to Single+First+Last Authored Papers | 694 | 710 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 891 | 930 |
| Ratio of Total Citations to Distinct Citing Papers | 1.44 | 1.46 |
| Self-Citation Percentage |
5.31%
|
|
Bredt, David S.
Janssen Pharmaceuticals Research & Development,
United States
2021 Rank: 16823
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Neurology & Neurosurgery
SubField 2:
Biochemistry & Molecular Biology
Rank in SubField 1: 977 out of 278898 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 16823 | 18770 |
| Total Cites | 1577 | 1646 |
| H-index | 20 | 21 |
| Hm-index | 10 | 10 |
| Number of Single Authored Papers | 9 | 9 |
| Total Cites to Single Authored Papers | 39 | 39 |
| Number of Single+First Authored Papers | 23 | 23 |
| Total Cites to Single+First Authored Papers | 260 | 260 |
| Number of Single+First+Last Authored Papers | 116 | 116 |
| Total Cites to Single+First+Last Authored Papers | 991 | 1030 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1078 | 1100 |
| Ratio of Total Citations to Distinct Citing Papers | 1.46 | 1.50 |
| Self-Citation Percentage |
4.19%
|
|
Bredt, David S.
Johnson & Johnson Pharmaceutical Research & Development, Raritan,
United States
2020 Rank: 16009
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Neurology & Neurosurgery
SubField 2:
Developmental Biology
Rank in SubField 1: 959 out of 227881 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 16009 | 17959 |
| Total Cites | 1213 | 1277 |
| H-index | 18 | 18 |
| Hm-index | 9 | 9 |
| Number of Single Authored Papers | 9 | 9 |
| Total Cites to Single Authored Papers | 28 | 28 |
| Number of Single+First Authored Papers | 23 | 23 |
| Total Cites to Single+First Authored Papers | 230 | 231 |
| Number of Single+First+Last Authored Papers | 112 | 112 |
| Total Cites to Single+First+Last Authored Papers | 776 | 806 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 807 | 834 |
| Ratio of Total Citations to Distinct Citing Papers | 1.50 | 1.53 |
| Self-Citation Percentage |
5.01%
|
|
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.